Generation Bio IPO

Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases.

Total Funding to Date$125.37MM
Register for Details

For more details on financing and valuation for Generation Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Generation Bio Ticker Symbol


Generation Bio Stock Price

$5.53 as of 12/1/22